Musculoskeletal Tumor | Voices Without Borders: PKUPH Experts Join CGTN Roundtable on Innovation and Humanity in Cancer Care Collaboration
2026-05-07
During National Anti-Cancer Week 2026, Professors Wei Ran and Xie Lu from Musculoskeletal Tumor Center at Peking University People’s Hospital (PKUPH) joined an international roundtable hosted by China Global Television Network (CGTN). The roundtable focused on “Innovation and Humanity in Cancer Care Collaboration”. The program brought together leading oncologists from China, Europe and beyond to discuss the future of cancer treatment and collaboration.
(Ref: CGTN Official Website)
During National Anti-Cancer Week 2026, Professors Wei Ran and Xie Lu from Musculoskeletal Tumor Center at Peking University People’s Hospital (PKUPH) joined an international roundtable hosted by China Global Television Network (CGTN). The roundtable focused on “Innovation and Humanity in Cancer Care Collaboration”. The program brought together leading oncologists from China, Europe and beyond to discuss the future of cancer treatment and collaboration.
The central theme was communication with patients at the time of diagnosis.
Professor Wei emphasized the importance of using clear, non-technical language to ease fear and build trust. He noted that for early-stage patients, clinicians should give them hope and confidence, while for patients in later stages, he said, emotional support and family guidance are equally important.
Professor Wei (Ref: CGTN Official Website)
Professor Xie said that fear often comes from uncertainty and stressed the value of ongoing, honest conversations. She also emphasized the importance of helping patients to regard certain cancers as long-term conditions that can be managed.
Professor Xie (Ref: CGTN Official Website)
The discussion also explored the role of new technologies. Experts agreed that precision medicine and artificial intelligence are reshaping cancer care, from identifying driver genes to improving surgical accuracy. They also talked about current limitations, particularly in rare cancers where data is limited. Technologies such as telepathology and real-time imaging were highlighted as tools that can improve access to expertise across regions.
(Ref: CGTN Official Website)
International collaboration was reinforced as crucial, particularly for rare tumors where single-center experience is insufficient. Experts further emphasized that sharing data and clinical experience across borders is key to progress in cancer treatment and better patient outcomes.
Looking ahead, the panel identified continued advances in immunotherapy, targeted therapy, and data integration as drivers of future progress. Although challenges remain, particularly with complex cancers, the discussion reflected a shared commitment to combining scientific innovation with patient-centered care, an approach that continues to guide oncology practice at PKUPH and beyond.
Full video available on the CGTN website: https://news.cgtn.com/news/2026-04-19/CGTN-Roundtable-Innovation-and-humanity-in-cancer-care-collaboration-1MtipXlNWPm/p.html
